Arterial thrombus formation: Novel mechanisms and targets

Hamostaseologie

Volumn 30, Issue 3, 2010, Pages 127-135

  Hagedorn, I ^a   Vogtle T ^a   Nieswandt, B ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Factor XII; Integrin activation; Platelets; Thrombus formation

Indexed keywords

BLOOD CLOTTING FACTOR 12; CALCIUM; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; KINDLIN3; LECTIN; MEMBRANE PROTEIN; PROTEIN CLEC 2; RAP1B PROTEIN; STROMAL INTERACTION MOLECULE 1; TALIN1; UNCLASSIFIED DRUG; FIBRINOLYTIC AGENT;

ANTICOAGULATION; ARTERY THROMBOSIS; CALCIUM CELL LEVEL; HEMOSTASIS; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS; BLOOD; BLOOD CLOTTING DISORDER; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ADHESIVENESS;

BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; CALCIUM; FACTOR XII; FIBRINOLYTIC AGENTS; HUMANS; INTEGRINS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 77957014978     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619045     Document Type: Review

References (103)

1. Abdullaev IF, Bisaillon JM, Potier M et al. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 2008; 103: 1289-1299.
2. Adams HP Jr, Effron MB, Torner J et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008; 39: 87-99.
3. Bergmeier W, Goerge T, Wang HW et al. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest 2007; 117: 1699-1707. (Pubitemid 46871354)
4. Bergmeier W, Oh-Hora M, McCarl CA et al. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 2009; 113: 675-678.
5. Bergmeier W, Piffath CL, Goerge T et al. The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA 2006; 103: 16900-16905. (Pubitemid 44737350)
6. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517-529.
7. Bertozzi CC, Schmaier AA, Mericko P et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010; doi 10.1182/blood-2010-02-270876.
8. Beyersdorf N, Braun A, Vogtle T et al. STIM1-independent T cell development and effector function in vivo. J Immunol 2009; 182: 3390-3397.
9. Braun A, Gessner JE, Varga-Szabo D et al. STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation. Blood 2009; 113: 1097-1104.
10. Braun A, Varga-Szabo D, Kleinschnitz C et al. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 2009; 113: 2056-2063.
11. Calderwood DA, Yan B, de Pereda JM et al. The phosphotyrosine binding-like domain of talin activates integrins. J Biol Chem 2002; 277: 21749-21758. (Pubitemid 34952326)
12. Chaipan C, Soilleux EJ, Simpson P et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol 2006; 80: 8951-8960. (Pubitemid 44359969)
13. Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM et al. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 2005; 115: 680-687. (Pubitemid 40322242)
14. Cifuni SM, Wagner DD, Bergmeier W. CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIb-beta3 in platelets. Blood 2008; 112: 1696-1703.
15. Crittenden JR, Bergmeier W, Zhang Y et al. Cal- DAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004; 10: 982-986. (Pubitemid 39273740)
16. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-1312.
17. Decrem Y, Rath G, Blasioli V et al. Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis. J Exp Med 2009; 206: 2381-2395.
18. Elvers M, Pozgaj R, Pleines I et al. Platelet hyper-reactivity and a prothrombotic phenotype in mice with a gain-of-function mutation in phospholipase Cgamma2. J Thromb Haemost 2010; doi 10.1111/j.1538-7836.2010. 03838.x.
19. Elvers M, Stegner D, Hagedorn I et al. Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal 2010; 3: ra1.
20. Falati S, Edmead CE, Poole AW. Glycoprotein Ib- V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets. Blood 1999; 94: 1648-1656. (Pubitemid 29411314)
21. Feske S. CRAC channelopathies. Pflugers Arch 2010; 460: 417-435.
22. Feske S, Gwack Y, Prakriya M et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006; 441: 179-185.
23. Fuller GL, Williams JA, Tomlinson MG et al. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem 2007; 282: 12397-12409.
24. Girolami A, Randi ML, Gavasso S et al. The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. J Thromb Thrombolysis 2004; 17: 139-143. (Pubitemid 39157964)
25. Grosse J, Braun A, Varga-Szabo D et al. An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice. J Clin Invest 2007; 117: 3540-3550. (Pubitemid 350097009)
26. Gruner S, Prostredna M, Aktas B et al. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy. Circulation 2004; 110: 2946-2951. (Pubitemid 39473622)
27. Gruner S, Prostredna M, Schulte V et al. Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 2003; 102: 4021-4027. (Pubitemid 37486984)
28. Gwack Y, Srikanth S, Oh-Hora M et al. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol 2008; 28: 5209-5222.
29. Hagedorn I, Schmidbauer S, Pleines I et al. Factor XIIa inhibitor recombinant human albumin Infestin- 4 abolishes occlusive arterial thrombus formation without affecting bleeding. Circulation 2010; 121: 1510-1517.
30. Hathaway DR, Adelstein RS. Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. Proc Natl Acad Sci USA 1979; 76: 1653-1657.
31. Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 186-193.
32. 2+ responses. Blood 1997; 90: 2615-2625.
33. Holtkotter O, Nieswandt B, Smyth N et al. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 2002; 277: 10789-10794. (Pubitemid 34952832)
34. Hughes CE, Pollitt AY, Mori J et al. CLEC-2 activates Syk through dimerisation. Blood 2010; 115: 2947-2955.
35. Kawasaki H, Springett GM, Toki S et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci USA 1998; 95: 13278-13283. (Pubitemid 28509562)
36. Kerrigan AM, Dennehy KM, Mourao-Sa D et al. CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J Immunol 2009; 182: 4150-4157.
37. Kleinschnitz C, De Meyer SF, Schwarz T et al. Deficiency of von Willebrand factor protects mice from ischemic stroke. Blood 2009; 113: 3600-3603.
38. Kleinschnitz C, Pozgajova M, Pham M et al. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007; 115: 2323-2330. (Pubitemid 46685900)
39. Kleinschnitz C, Stoll G, Bendszus M et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 2006; 203: 513-518.
40. Lecut C, Schoolmeester A, Kuijpers MJ et al. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol 2004; 24: 1727-1733. (Pubitemid 39180902)
41. Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 2003; 42: 423-438.
42. 2+ influx. Curr Biol 2005; 15: 1235-1241.
43. Macfarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as biochemical amplifier. Nature 1964; 202: 498-499.
44. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-1022. (Pubitemid 38737825)
45. Malinin NL, Zhang L, Choi J et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 2009; 15: 313-318.
46. Massberg S, Gawaz M, Gruner S et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003; 197: 41-49. (Pubitemid 36110256)
47. May F, Hagedorn I, Pleines I et al. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 2009; 114: 3464-3472.
48. Mazzucato M, Pradella P, Cozzi MR et al. Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor. Blood 2002; 100: 2793-2800.
49. 2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol 2009; 124: 1311-1318.
50. McDermott M, Wakelam MJ, Morris AJ. Phospholipase D. Biochem Cell Biol 2004; 82: 225-253.
51. Meves A, Stremmel C, Gottschalk K, Fassler R. The Kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol 2009; 19: 504-513.
52. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 2010; 9: 154-169.
53. Moser M, Nieswandt B, Ussar S et al. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008; 14: 325-330. (Pubitemid 351347914)
54. Müller F, Mutch NJ, Schenk WA et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009; 139: 1143-1156.
55. Munnix IC, Kuijpers MJ, Auger J et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol 2007; 27: 2484-2490. (Pubitemid 350203968)
56. Nesbitt WS, Kulkarni S, Giuliano S et al. Distinct glycoprotein Ib/V/IX and integrin alpha IIbbeta 3-dependent calcium signals cooperatively regulate platelet adhesion under flow. J Biol Chem 2002; 277: 2965-2972. (Pubitemid 34953332)
57. Nesbitt WS, Westein E, Tovar-Lopez FJ et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009; 15: 665-673.
58. Nieswandt B, Bergmeier W, Rackebrandt K et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 2000; 96: 2520-2527.
59. Nieswandt B, Bergmeier W, Schulte V et al. Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain. J Biol Chem 2000; 275: 23998-24002. (Pubitemid 30624690)
60. Nieswandt B, Brakebusch C, Bergmeier W et al. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20: 2120-2130. (Pubitemid 32410582)
61. Nieswandt B, Moser M, Pleines I et al. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J Exp Med 2007; 204: 3113-3118.
62. Nieswandt B, Schulte V, Bergmeier W et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 2001; 193: 459-469. (Pubitemid 32524477)
63. Nieswandt B, Varga-Szabo D, Elvers M. Integrins in platelet activation. J Thromb Haemost 2009; 7 Suppl 1: 206-299.
64. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003; 102: 449-461.
65. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006; 99: 1293-1304. (Pubitemid 44949665)
66. Oh-Hora M, Yamashita M, Hogan PG et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol 2008; 9: 432-443. (Pubitemid 351405113)
67. Ozaki Y, Asazuma N, Suzuki-Inoue K, Berndt MC. Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost 2005; 3: 1745-1751.
68. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 2005; 85: 757-810.
69. Petrich BG, Marchese P, Ruggeri ZM et al. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 2007; 204: 3103-3111.
70. Picard C, McCarl CA, Papolos A et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 2009; 360: 1971-1980.
71. Pleines I, Eckly A, Elvers M et al. Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in platelets. Blood 2010; 115: 3364-3373.
72. Pollitt AY, Grygielska B, Leblond B et al. Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerisation, secondary mediators and Rac. Blood 2010; 115: 2238-2946.
73. Quinn MJ, Byzova TV, Qin J et al. Integrin alphaIIbbeta3 and its antagonism. Arterioscler Thromb Vasc Biol 2003; 23: 945-952.
74. Rabie T, Varga-Szabo D, Bender M et al. Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood 2007; 110: 529-535. (Pubitemid 47105390)
75. Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest 1955; 34: 602-613.
76. Renne T, Pozgajova M, Gruner S et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 271-281. (Pubitemid 41043823)
77. 2+ thresholds and Ca-independent activation for shape-change and secretion. FEBS Lett 1982; 148: 21-26.
78. Roos J, DiGregorio PJ, Yeromin AV et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol 2005; 169: 435-445. (Pubitemid 40686694)
79. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-1234.
80. Savage B, mus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998; 94: 657-666.
81. Schuhmann MK, Stegner D, Berna-Erro A et al. Stromal interaction molecules 1 and 2 are key regulators of auto-reactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol 2010; 184: 1536-1542.
82. Schulte V, Rabie T, Prostredna M et al. Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor. Blood 2003; 101: 3948-3952. (Pubitemid 36857871)
83. Schulte V, Reusch HP, Pozgajova M et al. Two-phase antithrombotic protection after anti-glycoprotein VI treatment in mice. Arterioscler Thromb Vasc Biol 2006; 26: 1640-1647. (Pubitemid 44288995)
84. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004; 104: 1606-1615. (Pubitemid 39202265)
85. Stefanini L, Roden RC, Bergmeier W. CalDAG-GEFI is at the nexus of calcium-dependent platelet activation. Blood 2009; 114: 2506-2514.
86. Stiber J, Hawkins A, Zhang ZS et al. STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat Cell Biol 2008; 10: 688-697. (Pubitemid 351772934)
87. Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood 2008; 112: 3555-3562.
88. Suzuki-Inoue K, Fuller GL, Garcia A et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006; 107: 542-549. (Pubitemid 43076377)
89. Suzuki-Inoue K, Kato Y, Inoue O et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem 2007; 282: 25993-26001. (Pubitemid 47443800)
90. Svensson L, Howarth K, McDowall A et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 2009; 15: 306-312.
91. Tadokoro S, Shattil SJ, Eto K et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003; 302: 103-106. (Pubitemid 37210697)
92. Uhrin P, Zaujec J, Breuss JM et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010; 115: 4997-4005.
93. Van der Meijden PE, Munnix IC, Auger JM et al. Dual role of collagen in factor XII-dependent thrombus formation. Blood 2009; 114: 881-890.
94. Varga-Szabo D, Authi KS, Braun A et al. Store-operated Ca(2+) entry in platelets occurs independently of transient receptor potential (TRP) C1. Pflugers Arch 2008; 457: 377-387.
95. Varga-Szabo D, Braun A, Kleinschnitz C et al. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med 2008; 205: 1583-1591. (Pubitemid 351962022)
96. Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost 2009; 7: 1057-1066.
97. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008; 28: 403-412.
98. Vig M, DeHaven WI, Bird GS et al. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol 2008; 9: 89-96. (Pubitemid 350286208)
99. 2+ entry. Science 2006; 312: 1220-1223.
100. Watson SP, Asazuma N, Atkinson B et al. The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen. Thromb Haemost 2001; 86: 276-288. (Pubitemid 32663958)
101. Wu Y, Asazuma N, Satoh K et al. Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase. Blood 2003; 101: 3469-3476. (Pubitemid 36857929)
102. Yap CL, Anderson KE, Hughan SC et al. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3). Blood 2002; 99: 151-158.
103. 2+ channel activity. Proc Natl Acad Sci USA 2006; 103: 9357-9362.